Translational Biosciences, a subsidiary of Medistem Panama, has received the green light for a phase I/II clinical trial using human umbilical cord-derived mesenchymal stem cells for multiple sclerosis from the Comite Nacional de Bioetica de la Investigacion Institutional Review Board .
http://ift.tt/1h6lFkO
http://ift.tt/1h6lFkO
No comments:
Post a Comment